BioAdvance
Conshohocken, PA, United States · Seed → Series A
Their stated focus (public profile)
BioAdvance is an evergreen, mission-driven fund focused on early-stage life science companies in the Mid-Atlantic U.S. (along the I-95 corridor between New York City and Washington, D.C.). It invests primarily at the seed and Series A stages in therapeutics, medical devices, digital health, diagnostics, and research tools that improve human health. The fund aims to provide capital that enables companies to reach key de-risking milestones and attract follow-on venture capital or strategic funding.
Stages: Seed → Series A
Sectors: Life sciences, Medtech, Healthtech
Check size: $500,000 to $1,500,000 initial investment; up to $5 million over the lifecycle of a company
On file: 3 partners on record · 40 companies on record
Website: bioadvance.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.